Mark Basik
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 107 publications
The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression.
Journal: Cell reports
Published: August 01, 2026
ASO Visual Abstract: Impact of Ethnicity on the Uptake of Risk-Reducing Mastectomy in Unaffected BRCA1/2 and PALB2 Carriers in Canada.
Journal: Annals of surgical oncology
Published: April 09, 2026
ASO Visual Abstract: Adherence to Endocrine Prevention in Patients with Atypical Hyperplasia and Lobular Carcinoma In Situ: Promising Trends from Real-World Use of Low-Dose Tamoxifen.
Journal: Annals of surgical oncology
Published: March 13, 2026
Trends in breast reconstruction for BRCA1/2, PALB2 and other high penetrance germline pathogenic variant carriers undergoing risk reducing mastectomy.
Journal: Familial cancer
Published: January 13, 2026
Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2- and Triple-Negative Breast Cancer in Canada: The HER2- TRENDS Study.
Journal: Advances in therapy
Published: December 05, 2025
Lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in TNBC.
Journal: Cell reports. Medicine
Published: December 04, 2025
ASO Visual Abstract: Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing After 60 Years of Age.
Journal: Annals of surgical oncology
Published: November 10, 2025
Adherence to Endocrine Prevention in Patients with Atypical Hyperplasia and Lobular Carcinoma In Situ: Promising Trends from Real-World Use of Low-Dose Tamoxifen.
Journal: Annals of surgical oncology
Published: October 31, 2025
Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortium.
Journal: European journal of human genetics : EJHG
Published: September 30, 2025
Impact of Ethnicity on the Uptake of Risk Reducing Mastectomy in Unaffected BRCA1/2 and PALB2 Carriers in Canada.
Journal: Annals of surgical oncology
Published: September 25, 2025
Mechanisms of resistance to antibody-drug conjugates in breast cancer.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: August 29, 2025
Clinical Validation of Digital PCR-based ctDNA detection for risk stratification in residual triple negative breast cancer: TRICIA trial results.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 07, 2025
Last Updated: 09/26/2026